Does ambient PM<sub>2.5</sub> reduce the protective association of leisure-time physical activity with mortality? A systematic review, meta-analysis, and individual-level pooled analysis of cohort studies involving 1.5 million adults.

Ku, Po-Wen; Steptoe, Andrew; Hamer, Mark; Zaninotto, Paola; Stamatakis, Emmanuel; Lin, Ching-Heng; Yu, Bin; Hvidtfeldt, Ulla Arthur et al. · BMC Med · 2025

meta_analysis · Level I

Where this comes from

Abstract

This study assessed whether higher levels of fine particulate matter (PM<sub>2.5</sub>) reduce the protective effects of leisure-time physical activity (LTPA) on all-cause, cardiovascular, and cancer mortality, and explored the PM<sub>2.5</sub> threshold beyond which attenuation occurs. We conducted two complementary investigations. First, a systematic review and meta-analysis (per PRISMA guidelines) identified eligible cohort studies from PubMed, Web of Science, Embase, and SPORTDiscus (from inception to 6 January 2025) that examined the independent or joint associations of LTPA and PM₂.₅ with mortality among adults (≥ 18 years). Second, an individual-level pooled analysis using harmonized data from three cohorts was performed using Cox regression modeling to assess the associations observed in the meta-analysis. In Study One, a total of seven cohort studies (n = 1,515,094; deaths = 115,196) were included in the meta-analysis, revealing that the reduction in all-cause mortality risk diminished with higher PM<sub>2.5</sub> exposure. Meeting the recommended LTPA level (7.5-15 MET-h/week) reduced all-cause mortality risk by approximately 30% at PM<sub>2.5</sub> < 25 μg/m<sup>3</sup> but only 12-15% at 25 + μg/m<sup>3</sup>. Study Two (three cohorts; n = 869,038; deaths = 45,080) confirmed this pattern. Individuals meeting the recommended LTPA level (7.5-15 MET-h/week) had a lower risk of all-cause mortality compared to those in the highest-risk group (reference: < 1 MET-h/week and PM<sub>2.5</sub>: 35-50 μg/m<sup>3</sup>). Hazard ratios (HRs) varied by PM<sub>2.5</sub> exposure, with lower HRs indicating a greater protective effect: 35-50 μg/m<sup>3</sup> (HR = 0.75, 95% CI: 0.61-0.93), 25-35 μg/m<sup>3</sup> (HR = 0.67, 95% CI: 0.57-0.79), 15-25 μg/m<sup>3</sup> (HR = 0.34, 95% CI: 0.29-0.39), 10-15 μg/m<sup>3</sup> (HR = 0.34, 95% CI: 0.28-0.41), and < 10 μg/m<sup>3</sup> (HR = 0.30, 95% CI: 0.25-0.37). Higher levels of LTPA were generally associated with lower all-cause and cause-specific mortality across most PM₂.₅ exposure categories, but the protective effects were attenuated at PM₂.₅ levels 25 + μg/m<sup>3</sup> for all outcomes and became non-significant for cancer mortality at 35-50 μg/m<sup>3</sup>. LTPA is beneficial for all-cause, cardiovascular, and cancer mortality even at relatively high PM<sub>2.5</sub> levels, with greater benefits observed under cleaner air conditions. However, its protective effects are attenuated at 25 + μg/m<sup>3</sup> for all outcomes and become less evident at 35-50 μg/m<sup>3</sup>, particularly for cancer mortality. CRD42023395364.

Medical subject headings